Valuation: Pharmedic Pharmaceutical Medicinal

Market Cap 1,180B 46.08M 41.33M 38.09M 34.59M 65.46M 4.32B 67.29M 456M 182M 2.31B 173M 169M 7.32B P/E 2024
16.6x
P/E 2025 25.7x
Enterprise Value 1,139B 44.48M 39.89M 36.77M 33.39M 63.19M 4.17B 64.96M 440M 175M 2.23B 167M 163M 7.06B EV / Sales 2024
1.54x
EV / Sales 2025 2.75x
Free-Float
27.43%
Yield 2024
2.31%
Yield 2025 -
10-19 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
07-23 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-22 Tasco Pharmaceutical And Biological Company Limited acquired 11.60% stake in Pharmedic Pharmaceutical Medicinal Joint Stock Company. CI
05-07 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
01-21 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
21/10/25 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
07/10/25 PVI Infrastructure Investment Fund managed by PVI Fund Management Joint Stock Company acquired 21.64% stake in Pharmedic Pharmaceutical Medicinal Joint Stock Company. CI
25/08/25 Vu Hoang Viet acquired 5.03% stake in Pharmedic Pharmaceutical Medicinal Joint Stock Company. CI
21/07/25 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
18/04/25 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
20/01/25 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2024 CI
18/10/24 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
17/07/24 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
1 day-2.77%
1 week+5.33%
Current month+6.22%
1 month-0.47%
3 months-2.77%
6 months-0.78%
Current year-23.49%
1 week 114,300
Extreme 114300
130,000
1 month 112,100
Extreme 112100
130,000
Current year 109,000
Extreme 109000
185,500
1 year 109,000
Extreme 109000
189,000
3 years 73,600
Extreme 73600
189,000
5 years 59,000
Extreme 59000
189,000
10 years 36,100
Extreme 36100
189,000
Manager TitleAgeSince
Chief Executive Officer 70 16/08/2012
Chief Tech/Sci/R&D Officer 56 -
Corporate Officer/Principal 64 01/08/2019
Director TitleAgeSince
Director/Board Member 70 29/04/2014
Director/Board Member 64 20/04/2019
Director/Board Member 64 29/04/2014
Change 5-day change 1-year change 3-year change Capi.($)
-2.77%+5.33%-18.77%+54.15% 46.08M
+1.44%+1.63%+48.17%+139.63% 1,276B
-0.47%+5.49%+49.03%+90.68% 676B
+0.20%+2.76%+34.37%+112.06% 519B
-0.78%+0.51%+37.82%+66.66% 388B
-0.48%+2.34%+70.66%+46.02% 365B
-0.94%-0.88%+27.86%+57.27% 307B
+0.01%-1.16%+2.94%+35.27% 287B
0.00%+0.86%+43.74%+74.04% 252B
+0.92%+2.03%+44.62%+125.07% 212B
Average -0.55%+2.65%+34.05%+80.08% 428B
Weighted average by Cap. -0.45%+2.51%+42.69%+96.48%

Financials

2024 2025
Net sales 498B 19.46M 17.45M 16.08M 14.61M 27.65M 1.82B 28.42M 193M 76.73M 978M 73.04M 71.49M 3.09B 547B 21.35M 19.15M 17.65M 16.03M 30.33M 2B 31.18M 211M 84.18M 1.07B 80.13M 78.43M 3.39B
Net income 80.13B 3.13M 2.81M 2.59M 2.35M 4.45M 293M 4.57M 30.98M 12.34M 157M 11.75M 11.5M 497M 82.3B 3.22M 2.88M 2.66M 2.41M 4.57M 301M 4.69M 31.82M 12.68M 162M 12.07M 11.81M 511M
Net Debt -201B -7.86M -7.04M -6.49M -5.9M -11.16M -736M -11.47M -77.73M -30.97M -395M -29.48M -28.85M -1.25B -40.88B -1.6M -1.43M -1.32M -1.2M -2.27M -150M -2.33M -15.8M -6.3M -80.22M -5.99M -5.87M -254M
Projected Income Statement - Annual - Pharmedic Pharmaceutical Medicinal
Logo Pharmedic Pharmaceutical Medicinal
Pharmedic Pharmaceutical Medicinal Joint Stock Company is a Vietnam-based company principally engaged in the manufacturing and distributing of pharmaceutical products, medicines, cosmetic and other products used in the healthcare sector. In addition, the Company is involved in the provision of printing services of plastic, paper and aluminum packagings. Moreover, it is active in the manufacture and trading of chemical products, such as pesticides and detergents for household and medical usage. During the year ended December 31, 2012, 97.24% of the Company's total revenue came from the sale of finished products. As of December 31, 2012, the Company was an affiliate of Saigon Pharmaceutical Company Limited (SAPHARCO), and it had a factory in Ho Chi Minh City, Vietnam.
Employees
494
Date Price Change Volume
10/11/26 ₫126,400.00 -2.77% 3,246
09/11/26 ₫130,000.00 +4.00% 2,002
06/11/26 ₫125,000.00 +6.02% 4,414
05/11/26 ₫117,900.00 -1.59% 2,110
04/11/26 ₫119,800.00 -0.17% 230